20/20 Biolabs
(NASDAQ) AIDX
20/20 Biolabs Financials at a Glance
Market Cap
$10.23M
Revenue (TTM)
$1.65M
Net Income (TTM)
$5.66M
EPS (TTM)
$0.00
P/E Ratio
4.09
Dividend
$0.00
Beta (Volatility)
-2.32 (Low)
Dividend
$0.00
Beta (Volatility)
-2.32 (Low)
Price
$2.03
Volume
1,406
Open
$2.01
Price
$2.03
Volume
1,406
Open
$2.01
Previous Close
$1.88
Daily Range
$2.01 - $2.16
52-Week Range
$1.70 - $50.00
Dividend
$0.00
Beta (Volatility)
-2.32 (Low)
Price
$2.03
Volume
1,406
Open
$2.01
Previous Close
$1.88
Daily Range
$2.01 - $2.16
52-Week Range
$1.70 - $50.00
AIDX News
AIDX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout 20/20 Biolabs
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
20
CEO
Jonathan Cohen
Website
2020biolabs.comHeadquarters
Gaithersburg, MD 20877, US
AIDX Financials
Key Financial Metrics (TTM)
Gross Margin
32%
Operating Margin
-2%
Net Income Margin
-2%
Return on Equity
0%
Return on Capital
-2%
Return on Assets
-64%
Earnings Yield
24.45%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$10.23M
Shares Outstanding
5.44M
Volume
1.41K
Short Interest
0.00%
Avg. Volume
372.61K
Financials (TTM)
Gross Profit
$360.31K
Operating Income
$5.66M
EBITDA
$5.53M
Operating Cash Flow
$2.60M
Capital Expenditure
$5.00
Free Cash Flow
$2.60M
Cash & ST Invst.
$1.78M
Total Debt
$1.51M
20/20 Biolabs Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$417.98K
-0.3%
Gross Profit
$145.07K
+7703.4%
Gross Margin
34.71%
N/A
Market Cap
$10.23M
N/A
Market Cap/Employee
$787.03K
N/A
Employees
13
N/A
Net Income
$825.54K
+58.6%
EBITDA
$780.95K
+56.2%
Quarterly Fundamentals
Net Cash
$550.91K
N/A
Accounts Receivable
$136.87K
N/A
Inventory
$54.76K
N/A
Long Term Debt
$1.52M
N/A
Short Term Debt
$173.35K
N/A
Return on Assets
-64.04%
N/A
Return on Invested Capital
-1.64%
N/A
Free Cash Flow
$536.45K
N/A
Operating Cash Flow
$536.45K
N/A